Back

Heron Therapeutics Quote, Financials, Valuation and Earnings

Sell

HRTX
Heron Therapeutics

Last Price:

3.00

Seasonality Move:

3.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Heron Therapeutics Price Quote

$3.00

+0.19 (+6.76%)

(Updated: May 15, 2024 at 4:35 PM ET)

Heron Therapeutics Key Stats

Sell

Heron Therapeutics (HRTX) is a Sell

Day range:

$2.80 - $2.93

52-week range:

$0.50 - $3.22

Dividend yield:

P/E ratio:

0.00

P/S ratio:

3.02

P/B ratio:

Volume:

1.1M

Avg. volume:

2.1M

1-year change:

100.71%

Market cap:

$423.3M

Revenue:

$127M

EPS:

$-0.59

How Much Does Heron Therapeutics Make?

How Much Are Heron Therapeutics's Sales Annually?
HRTX Revenues are $127M
How Much Profit Does Heron Therapeutics's Make A Year?
HRTX net income is -$110.6M

Is Heron Therapeutics Growing As A Company?

What Is Heron Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.17%
What Is Heron Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Heron Therapeutics Stock Price Performance

Did Heron Therapeutics Stock Go Up Last Month?
Heron Therapeutics share price went down by -3.44% last month
Did HRTX's Share Price Rise Over The Last Year?
HRTX share price rose by 100.71% over the past 1 year

What Is Heron Therapeutics 52-Week High & Low?

What Is Heron Therapeutics’s 52-Week High Share Price?
Heron Therapeutics has traded as high as $3.22 over the past 52 weeks
What Is Heron Therapeutics’s 52-Week Low Share Price?
Heron Therapeutics has traded as low as $0.50 over the past 52 weeks

Heron Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Heron Therapeutics?

How Much Debt Does Heron Therapeutics Have?
Total long term debt quarterly is $174M
How Much Cash Does Heron Therapeutics Have?
Cash and short term investments quarterly total is $71.5M
What Is Heron Therapeutics’s Book Value Per Share?
Book value per share is -0.22

Is Heron Therapeutics Cash Flow Positive?

What Is HRTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$43.4M
What Is Heron Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $54.3M
What Is Heron Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$17.6M

Heron Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
HRTX return on invested capital is -60.08%
What Is Heron Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -37.08%
What Is HRTX Return On Equity?
ROE is a measure of profitability and is 0%

Heron Therapeutics Earnings Date & Stock Price

What Is Heron Therapeutics's Stock Price Today?
A single share of HRTX can be purchased today for 2.81
What Is Heron Therapeutics’s Stock Symbol?
Heron Therapeutics trades on the nasdaq under the ticker symbol: HRTX
When Is Heron Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Heron Therapeutics is scheduled on August 14, 2024
When Is HRTX's next ex-dividend date?
Heron Therapeutics's next ex-dividend date is May 12, 2020
How To Buy Heron Therapeutics Stock?
You can buy Heron Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Heron Therapeutics Competitors

Who Are Heron Therapeutics's Competitors?
Below is a list of companies who compete with Heron Therapeutics or are related in some way:
- Aldeyra Therapeutics Inc (ALDX)
- Alpine Immune Sciences Inc (ALPN)
- Esperion Therapeutics Inc (ESPR)
- Ocular Therapeutix Inc (OCUL)
- United Therapeutics Corp (UTHR)

Heron Therapeutics Dividend Yield